Lauren Corregano1, Katelyn Bastert1, Joel Correa da Rosa2, Rhonda G Kost1. 1. Clinical Research Support Office, The Rockefeller University Center for Clinical and Translational Science, New York, New York, USA. 2. Department of Research Design and Biostatistics, The Rockefeller University Center for Clinical and Translational Science, New York, New York, USA.
Abstract
BACKGROUND: Achieving timely accrual into clinical research studies remains a challenge for clinical translational research. We developed an evaluation measure, the Accrual Index (AI), normalized for sample size and study duration, using data from the protocol and study management databases. We applied the AI retrospectively and prospectively to assess its utility. METHODS: Accrual Target, Projected Time to Accrual Completion (PTAC), Evaluable Subjects, Dates of Recruitment Initiation, Analysis, and Completion were defined. AI is (% Accrual Target accrued/% PTAC elapsed). Changes to recruitment practices were described, and data extracted from study management databases. RESULTS: December 2014 (or final) AI was analyzed for 101 studies initiating recruitment from 2007 to 2014. Median AI was ≥1 for protocols initiating recruitment in 2011, 2013, and 2014. The AI varied widely for studies pre-2013. Studies with AI > 4 utilized convenience samples for recruitment. Data-justified PTAC was refined in 2013-2014 after which the AI range narrowed. Protocol characteristics were not associated with study AI. CONCLUSION: Protocol AI reflects the relative agreement between accrual feasibility assessment (PTAC), and accrual performance, and is affected by recruitment practices. The AI may be useful in managing accountability, modeling accrual, allocating recruitment resources, and testing innovations in recruitment practices.
BACKGROUND: Achieving timely accrual into clinical research studies remains a challenge for clinical translational research. We developed an evaluation measure, the Accrual Index (AI), normalized for sample size and study duration, using data from the protocol and study management databases. We applied the AI retrospectively and prospectively to assess its utility. METHODS: Accrual Target, Projected Time to Accrual Completion (PTAC), Evaluable Subjects, Dates of Recruitment Initiation, Analysis, and Completion were defined. AI is (% Accrual Target accrued/% PTAC elapsed). Changes to recruitment practices were described, and data extracted from study management databases. RESULTS: December 2014 (or final) AI was analyzed for 101 studies initiating recruitment from 2007 to 2014. Median AI was ≥1 for protocols initiating recruitment in 2011, 2013, and 2014. The AI varied widely for studies pre-2013. Studies with AI > 4 utilized convenience samples for recruitment. Data-justified PTAC was refined in 2013-2014 after which the AI range narrowed. Protocol characteristics were not associated with study AI. CONCLUSION: Protocol AI reflects the relative agreement between accrual feasibility assessment (PTAC), and accrual performance, and is affected by recruitment practices. The AI may be useful in managing accountability, modeling accrual, allocating recruitment resources, and testing innovations in recruitment practices.
Authors: Seth W Glickman; John G McHutchison; Eric D Peterson; Charles B Cairns; Robert A Harrington; Robert M Califf; Kevin A Schulman Journal: N Engl J Med Date: 2009-02-19 Impact factor: 91.245
Authors: Donna Brassil; Rhonda G Kost; Kathleen A Dowd; Arlene M Hurley; Tyler-Lauren Rainer; Barry S Coller Journal: Clin Transl Sci Date: 2014-01-09 Impact factor: 4.689
Authors: Rhonda G Kost; Sabrena Mervin-Blake; Rose Hallarn; Charles Rathmann; H Robert Kolb; Cheryl Dennison Himmelfarb; Toni D'Agostino; Eric P Rubinstein; Ann M Dozier; Kathryn G Schuff Journal: Acad Med Date: 2014-08 Impact factor: 6.893
Authors: Jihad S Obeid; Laura M Beskow; Marie Rape; Ramkiran Gouripeddi; R Anthony Black; James J Cimino; Peter J Embi; Chunhua Weng; Rebecca Marnocha; John B Buse Journal: J Clin Transl Sci Date: 2017-08